Ph.D., Medicinal Chemistry, September 2021. University de Tours, France.
Master of Pharmacy in Medicinal Chemistry, March 2016. University of Gezira, Faculty of Pharmacy, Sudan.
Bachelor of Pharmacy, March 2010. University of Gezira, Faculty of Pharmacy, Sudan.
Experience
Assistant professor of pharmaceutical chemistry, RACOP, UMHSU, from September 2024-present.
Assistant professor of pharmaceutical chemistry, Faculty of Pharmacy, University of Gezira, Sudan, from September 2021-September 2024.
Lecturer of pharmaceutical chemistry, Faculty of Pharmacy, University of Gezira, Sudan, from April 2016-September 2021.
Teaching Assistant of pharmaceutical chemistry, Faculty of Pharmacy, University of Gezira, Sudan, from December 2015-April 2016.
Courses Taught
Innovations & Entrepreneurship in Pharmacy (PIE503)
General Chemistry for Pharmacy (PGC-103P)
Pharmaceutical Calculations (PPC203)
Pharmaceutical Analysis-1 (PRA213)
Publications
Repurposing of approved drugs for targeting CDK4/6 and aromatase protein using molecular docking and molecular dynamics studies.
Exploring the potential of approved drugs for triple-negative breast cancer treatment by targeting casein kinase 2: Insights from computational studies.
Identification of Novel Natural Dual HDAC and Hsp90 Inhibitors for Metastatic TNBC Using e-Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics Studies.
Insights into the Inhibition of Mycolic Acid Synthesis by Cytosporone E Derivatives for Tuberculosis Treatment Via an In Silico Multi-target Approach.
Design of Novel Phosphatidylinositol 3-Kinase Inhibitors for Non-Hodgkin's Lymphoma: Molecular Docking, Molecular Dynamics, and Density Functional Theory Studies on Gold Nanoparticles.
Cytosporone E analogues as BRD4 inhibitors for cancer treatment: Molecular docking and molecular dynamic investigations.
Drug repurposing against main protease and RNA-dependent RNA polymerase of SARS-CoV-2 using molecular docking, MMGBSA calculations, and molecular dynamics.
Phthalide Derivatives as Dihydrofolate Reductase Inhibitors for Malaria: Molecular Docking and Molecular Dynamics.
Drug repurposing for SARS-CoV-2 main protease: Molecular docking and molecular dynamics investigations.
Design of Novel Coumarins as Potent Mcl-1 Inhibitors for Cancer Treatment Guided by 3D-QSAR, Molecular Docking and Molecular Dynamics.
Identification of Novel Transmembrane Protease Serine Type 2 Drug Candidates for COVID-19 Using Computational Studies.
Synthesis, antibacterial and cytotoxic evaluation of cytosporone E and analogs.
Synthesis and antibacterial activity of racemic paecilocin A and its derivatives against methicillin-sensitive and -resistant Staphylococcus aureus.
Achievements
PhD scholarship at Laboratoire Synthese et Isolement de Molecules Bioactives (SIMBA, EA 7502), University de Tours, Tours, France. Sponsored by: Ministry of Higher Education (Sudan) and French Government.